Cargando…
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies
Nowadays, one of the main challenges clinicians face is malignancies. Through the progression of technology in recent years, tumor nature and tumor microenvironment (TME) can be better understood. Because of immune system involvement in tumorigenesis and immune cell dysfunction in the tumor microenv...
Autores principales: | Faeq, Mohammed Hikmat, Al-Haideri, Maysoon, Mohammad, Talar Ahmad Merza, gharebakhshi, Farshad, Marofi, Faroogh, Tahmasebi, Safa, Modaresahmadi, Shadan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119530/ https://www.ncbi.nlm.nih.gov/pubmed/37083979 http://dx.doi.org/10.1007/s12032-023-02019-4 |
Ejemplares similares
-
CAR-T cell combination therapy: the next revolution in cancer treatment
por: Al-Haideri, Maysoon, et al.
Publicado: (2022) -
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
por: Mardi, Amirhossein, et al.
Publicado: (2022) -
The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence
por: Al-Haideri, Maysoon T., et al.
Publicado: (2023) -
MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
por: Marofi, Faroogh, et al.
Publicado: (2021) -
CAR T cells in solid tumors: challenges and opportunities
por: Marofi, Faroogh, et al.
Publicado: (2021)